The chief of the Movement Disorders Division at Yale School of Medicine discusses the nuance around patient choice in Huntington disease testing and providing treatment regardless of confirmation. [WATCH TIME: 3 minutes]
Veronica Santini, MD, MA
Advertisement
Associate Professor of Neurology, Clinical Chief of the Movement Disorders Division, and Chief of the Comprehensive Parkinson's Disease Program, Yale School of Medicine
Articles by Veronica Santini, MD, MA
Advertisement
Latest Updated Articles
Navigating the Patient Decision to Pursue Huntington Disease Testing: Veronica Santini, MD, MAPublished: October 7th 2025 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Multi-Arm Phase 2 Trial Fails to Show Efficacy for Cognitive Programs in Treating Long COVID
2
The Rationale and Early Supportive Data for NLRP3 Inhibitor VTX3232 in Parkinson Disease: Mark Forman, MD, PhD
3
CAR-T Therapy KYV-101 Achieves Durable Response in Phase 2/3 KYSA-6 Trial of Myasthenia Gravis
4
First Patient Dosed in Phase 2 Extension Study of Sabirnetug in Early Alzheimer Disease
5
